These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
900 related items for PubMed ID: 18957615
1. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D. Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E238-43. PubMed ID: 18957615 [Abstract] [Full Text] [Related]
2. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age]. Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E. Akush Ginekol (Sofiia); 2013 Feb; 52 Suppl 1():16-23. PubMed ID: 24294740 [Abstract] [Full Text] [Related]
3. Comparison of serum anti-Müllerian hormone levels in normal weight and overweight-obese adolescent patients with polycystic ovary syndrome. Cengiz H, Ekin M, Dagdeviren H, Yildiz Ş, Kaya C, Kanawati A. Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():46-50. PubMed ID: 25036408 [Abstract] [Full Text] [Related]
4. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome]. Li Y, Wei LN, Xiong YL, Liang XY. Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609 [Abstract] [Full Text] [Related]
5. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome. Olszanecka-Glinianowicz M, Madej P, Owczarek A, Chudek J, Skałba P. Clin Endocrinol (Oxf); 2015 Jul; 83(1):98-104. PubMed ID: 25440474 [Abstract] [Full Text] [Related]
11. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS. Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325 [Abstract] [Full Text] [Related]
12. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Panidis D, Tziomalos K, Misichronis G, Papadakis E, Betsas G, Katsikis I, Macut D. Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419 [Abstract] [Full Text] [Related]
13. Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome. Köninger A, Koch L, Edimiris P, Enekwe A, Nagarajah J, Kasimir-Bauer S, Kimmig R, Strowitzki T, Schmidt B. Arch Gynecol Obstet; 2014 Nov; 290(5):1023-30. PubMed ID: 24961320 [Abstract] [Full Text] [Related]
17. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women. Yue CY, Lu LK, Li M, Zhang QL, Ying CM. PLoS One; 2018 Nov; 13(8):e0203129. PubMed ID: 30153296 [Abstract] [Full Text] [Related]
18. Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome. Diamanti-Kandarakis E, Piouka A, Livadas S, Piperi C, Katsikis I, Papavassiliou AG, Panidis D. Eur J Endocrinol; 2009 May; 160(5):847-53. PubMed ID: 19208775 [Abstract] [Full Text] [Related]
19. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome? Skałba P, Cygal A, Madej P, Dąbkowska-Huć A, Sikora J, Martirosian G, Romanik M, Olszanecka-Glinianowicz M. Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527 [Abstract] [Full Text] [Related]
20. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome. Bradbury RA, Lee P, Smith HC. Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):552-557. PubMed ID: 28597496 [Abstract] [Full Text] [Related] Page: [Next] [New Search]